ILONA RASKINA: Open Payments
NPI 1982935680 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,772 in 106 payments from 18 companies in 2025. Trend: 2023 $1,800 · 2024 $2,823 · 2025 $3,772
Food & beverage: $3,772
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $475 |
| Philips North America LLC | 15 | $415 |
| Amgen Inc. | 6 | $304 |
| Abbott Laboratories | 2 | $287 |
| AstraZeneca Pharmaceuticals LP | 4 | $286 |
| E.R. Squibb & Sons, L.L.C. | 8 | $285 |
| ABIOMED | 10 | $264 |
| Novartis Pharmaceuticals Corporation | 12 | $252 |
| Merck Sharp & Dohme LLC | 10 | $251 |
| GlaxoSmithKline, LLC. | 8 | $155 |
Products named: JARDIANCE, REPATHA, ECC Solutions, LEQVIO, VERQUVO, CAMZYOS, FARXIGA, ELIQUIS.
Industry payments across NY — which companies pay providers there.
